$XFOR 4/A SEC Filings

Filed On	Filing
03 Jun 2025	Form 4/A: Baldry Mark, Chief Commercial Officer Received 1,032 shares as a grant or award ($2.56K)
28 Feb 2024	Form 4/A: Arbet-Engels Christophe, Chief Medical Officer Granted 180,816 Stock Appreciation Right
02 Apr 2019	Form 4/A: Bridger Gary, Director Granted 28,424 Stock Option (right to buy)
02 Apr 2019	Form 4/A: Blech Isaac, Director Granted 77,650 Stock Option (right to buy)
02 Apr 2019	Form 4/A: Wyzga Michael S, Director Granted 77,178 Stock Option (right to buy)
15 Mar 2019	Form 4/A: Mostafa Adam S., See Remarks Granted 62,633 Stock Option (right to buy)
08 Mar 2018	Form 4/A: Mcguire Terrance, Director Granted 25,000 Common Stock (right to buy)
05 Mar 2018	Form 4/A: Ross Michael Jay, Director Granted 25,000 Common Stock (right to buy)
05 Mar 2018	Form 4/A: Schulman Amy W, Director Granted 25,000 Common Stock (right to buy)
05 Mar 2018	Form 4/A: Nessi Claudio, Director Granted 25,000 Common Stock (right to buy)
05 Mar 2018	Form 4/A: Mcgirr David W J, Director Granted 25,000 Stock Option (right to buy)
05 Mar 2018	Form 4/A: Gerngross Tillman U., Director Granted 25,000 Stock Option (right to buy)
05 Mar 2018	Form 4/A: Gordon Carl L, Director Granted 25,000 Stock Option (right to buy)
05 Mar 2018	Form 4/A: Clark William D, Director Granted 25,000 Stock Option (right to buy)

Comments